<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Iwakami N</submitter><funding>Ministry of Education, Culture, Sports, Science and Technology</funding><pagination>e12741</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7358799</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The early repolarization pattern (ERP) in electrocardiography (ECG) has been considered as a risk for ventricular fibrillation (VF), but effective methods for identification of malignant ERP are still required. We investigated whether high spatiotemporal resolution 64-channel magnetocardiography (MCG) would enable distinction between benign and malignant ERPs.&lt;h4>Methods&lt;/h4>Among all 2,636 subjects who received MCG in our facility, we identified 116 subjects (43 ± 18 years old, 54% male) with inferior and/or lateral ERP in ECG and without structural heart disease, including 13 survivors of VF (ERP-VF(+)) and 103 with no history of VF (ERP-VF(-)). We measured the following MCG parameters in a time-domain waveform of relative current magnitude: (a) QRS duration (MCG-QRSD), (b) root-mean-square of the last 40 ms (MCG-RMS40), and (c) low amplitude (&lt;10% of maximal) signal duration (MCG-LAS).&lt;h4>Results&lt;/h4>Compared to ERP-VF(-), ERP-VF(+) subjects presented a significantly longer MCG-QRS (108 ± 24 vs. 91 ± 23 ms, p = .02) and lower MCG-RMS40 (0.10 ± 0.08 vs. 0.25 ± 0.20, p = .01) but no difference in MCG-LAS (38 ± 22 vs. 29 ± 23 ms, p = .17). MCG-QRSD and MCG-RMS40 showed significantly larger area under the ROC curve compared to J-peak amplitude in ECG (0.72 and 0.71 vs. 0.50; p = .04 and 0.03). The sensitivity, specificity, and odds ratio for identifying VF(+) based on MCG-QRSD ≥ 100 ms and MCG-RMS40 ≤ 0.24 were 69%, 74%, and 6.33 (95% CI, 1.80-22.3), and 92%, 48%, and 10.9 (95% CI, 1.37-86.8), respectively.&lt;h4>Conclusion&lt;/h4>Magnetocardiography is an effective tool to distinguish malignant and benign ERPs.</pubmed_abstract><journal>Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc</journal><pubmed_title>Identification of malignant early repolarization pattern by late QRS activity in high-resolution magnetocardiography.</pubmed_title><pmcid>PMC7358799</pmcid><funding_grant_id>15K09150</funding_grant_id><pubmed_authors>Nishimura K</pubmed_authors><pubmed_authors>Sun W</pubmed_authors><pubmed_authors>Shishido T</pubmed_authors><pubmed_authors>Furukawa TA</pubmed_authors><pubmed_authors>Sato T</pubmed_authors><pubmed_authors>Yamada-Inoue Y</pubmed_authors><pubmed_authors>Sugimachi M</pubmed_authors><pubmed_authors>Nagase S</pubmed_authors><pubmed_authors>Takaki H</pubmed_authors><pubmed_authors>Aiba T</pubmed_authors><pubmed_authors>Shimizu W</pubmed_authors><pubmed_authors>Yasuda S</pubmed_authors><pubmed_authors>Kamakura S</pubmed_authors><pubmed_authors>Kusano K</pubmed_authors><pubmed_authors>Iwakami N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of malignant early repolarization pattern by late QRS activity in high-resolution magnetocardiography.</name><description>&lt;h4>Background&lt;/h4>The early repolarization pattern (ERP) in electrocardiography (ECG) has been considered as a risk for ventricular fibrillation (VF), but effective methods for identification of malignant ERP are still required. We investigated whether high spatiotemporal resolution 64-channel magnetocardiography (MCG) would enable distinction between benign and malignant ERPs.&lt;h4>Methods&lt;/h4>Among all 2,636 subjects who received MCG in our facility, we identified 116 subjects (43 ± 18 years old, 54% male) with inferior and/or lateral ERP in ECG and without structural heart disease, including 13 survivors of VF (ERP-VF(+)) and 103 with no history of VF (ERP-VF(-)). We measured the following MCG parameters in a time-domain waveform of relative current magnitude: (a) QRS duration (MCG-QRSD), (b) root-mean-square of the last 40 ms (MCG-RMS40), and (c) low amplitude (&lt;10% of maximal) signal duration (MCG-LAS).&lt;h4>Results&lt;/h4>Compared to ERP-VF(-), ERP-VF(+) subjects presented a significantly longer MCG-QRS (108 ± 24 vs. 91 ± 23 ms, p = .02) and lower MCG-RMS40 (0.10 ± 0.08 vs. 0.25 ± 0.20, p = .01) but no difference in MCG-LAS (38 ± 22 vs. 29 ± 23 ms, p = .17). MCG-QRSD and MCG-RMS40 showed significantly larger area under the ROC curve compared to J-peak amplitude in ECG (0.72 and 0.71 vs. 0.50; p = .04 and 0.03). The sensitivity, specificity, and odds ratio for identifying VF(+) based on MCG-QRSD ≥ 100 ms and MCG-RMS40 ≤ 0.24 were 69%, 74%, and 6.33 (95% CI, 1.80-22.3), and 92%, 48%, and 10.9 (95% CI, 1.37-86.8), respectively.&lt;h4>Conclusion&lt;/h4>Magnetocardiography is an effective tool to distinguish malignant and benign ERPs.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-04-19T23:04:42.078Z</modification><creation>2025-04-19T23:04:42.078Z</creation></dates><accession>S-EPMC7358799</accession><cross_references><pubmed>31955494</pubmed><doi>10.1111/anec.12741</doi></cross_references></HashMap>